SRTA - Strata Critical Medical, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.25
DETAILS
HIGH:
$7.25
LOW:
$7.25
MEDIAN:
$7.25
CONSENSUS:
$7.25
UPSIDE:
35.14%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 197.1 | 248.7 | 225.2 | 146.1 | 50.5 | 23.4 | 31.2 |
| Cost of Revenue | 156.0 | 189.8 | 183.1 | 123.8 | 40.0 | 21.1 | 26.5 |
| Gross Profit | 41.1 | 58.9 | 42.1 | 22.3 | 10.5 | 2.3 | 4.7 |
| Operating Expenses | |||||||
| R&D Expenses | 3.1 | 3.2 | 4.6 | 5.5 | 1.7 | 0.9 | 0.8 |
| SG&A Expenses | 60.9 | 89.7 | 105.6 | 70.3 | 32.9 | 11.8 | 15.5 |
| Other Expenses | (0.4) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 63.5 | 92.8 | 110.2 | 75.8 | 34.6 | 12.7 | 16.2 |
| Operating Income | |||||||
| Operating Income | (22.4) | (33.9) | (68.1) | (53.5) | (24.1) | (10.4) | (11.5) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Interest Income | 4.2 | 7.2 | 8.4 | 3.4 | 0.5 | 0.2 | 0.7 |
| Profitability | |||||||
| EBITDA | (14.2) | (21.6) | (50.4) | (22.3) | (43.1) | (9.8) | (11.1) |
| EBIT | (22.4) | (27.6) | (57.5) | (28.0) | (43.7) | (10.4) | (11.5) |
| Income Before Tax | (20.1) | (27.6) | (57.5) | (28.0) | (43.7) | (10.2) | (10.8) |
| Income Tax Expense | 0 | (0.3) | (1.5) | (0.8) | (3.6) | 0 | 0 |
| Net Income | 41.3 | (27.3) | (56.1) | (27.3) | (40.1) | (10.2) | (10.8) |
| Per Share Data | |||||||
| EPS (Basic) | -0.19 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 | -1.47 |
| EPS (Diluted) | -0.19 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 | -1.47 |
| Shares Outstanding | 82.5 | 77.5 | 73.5 | 71.2 | 70.1 | 12.5 | 7.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 31.0 | 18.4 | 27.9 | 41.3 | 2.6 | 12.2 | 1.3 |
| Short-Term Investments | 30.3 | 108.8 | 138.3 | 150.7 | 279.4 | 0 | 276.3 |
| Net Receivables | 40.0 | 21.6 | 21.0 | 10.9 | 5.5 | 1.1 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0.5 | 0.5 | 0 |
| Other Current Assets | 25.0 | 12.0 | 19.1 | 3.1 | 0.1 | 0.1 | (276.1) |
| Total Current Assets | 126.2 | 160.7 | 206.3 | 218.1 | 294.9 | 14.4 | 1.4 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 39.6 | 39.8 | 26.4 | 19.7 | 2.8 | 2.5 | 0 |
| Goodwill | 88.2 | 41.0 | 40.4 | 39.4 | 13.3 | 0 | 0 |
| Intangible Assets | 47.5 | 13.7 | 20.5 | 46.4 | 24.4 | 0.5 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0.2 | 0.2 | 276.3 |
| Other Non-Current Assets | 24.0 | 1.4 | 1.4 | 1.4 | 0.2 | 0.1 | 0 |
| Total Non-Current Assets | 199.3 | 95.9 | 88.7 | 106.9 | 40.9 | 3.3 | 276.3 |
| Total Assets | 325.5 | 256.7 | 294.9 | 325.0 | 335.9 | 17.7 | 277.7 |
| Current Liabilities | |||||||
| Account Payables | 19.1 | 0 | 0 | 16.5 | 6.4 | 0.8 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 1.2 | 0.2 |
| Deferred Revenue | 0 | 6.7 | 6.8 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 12.8 | 23.9 | 6.7 | 6.0 | 4.0 | 0.1 |
| Total Current Liabilities | 19.8 | 22.7 | 35.5 | 26.6 | 12.8 | 6.3 | 0.4 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Deferred Tax Liabilities | 0.3 | 0.2 | 0.5 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 23.6 | 5.8 | 5.0 | 9.0 | 31.5 | 0 | 0 |
| Total Non-Current Liabilities | 26.6 | 12.0 | 25.1 | 23.9 | 31.7 | 0.3 | 0.2 |
| Total Liabilities | 46.4 | 34.7 | 60.6 | 50.5 | 44.5 | 6.6 | 272.7 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (145.6) | (186.9) | (159.8) | (103.7) | (76.4) | (37.1) | 0.8 |
| Accumulated Other Comprehensive Income | 0 | 1.8 | 4.0 | 2.3 | (0.9) | 0 | 0 |
| Total Stockholders' Equity | 279.1 | 221.9 | 234.3 | 274.5 | 291.4 | 11.1 | 5.0 |
| Total Liabilities & Equity | 325.5 | 256.7 | 294.9 | 325.0 | 335.9 | 17.7 | 277.7 |
| Debt Metrics | |||||||
| Total Debt | 3.3 | 9.3 | 24.5 | 18.3 | 0.7 | 1.9 | 0.5 |
| Net Debt | (27.7) | (9.1) | (3.3) | (23.0) | (1.9) | (10.3) | (0.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | 41.3 | (27.3) | (56.1) | (27.3) | (40.1) | (10.2) | (10.8) |
| Depreciation & Amortization | 8.2 | 6.0 | 7.1 | 5.7 | 0.6 | 0.5 | 0.5 |
| Stock-Based Compensation | 17.8 | 19.9 | 12.5 | 8.3 | 9.6 | 0.5 | 0.3 |
| Change in Working Capital | (9.1) | (3.0) | (6.7) | (0.0) | (2.2) | (1.7) | (0.3) |
| Other Non-Cash Items | (107.6) | 2.2 | 12.3 | (23.1) | 20.1 | 0 | 0.0 |
| Operating Cash Flow | (48.9) | (2.5) | (32.3) | (37.1) | (15.6) | (10.8) | (10.3) |
| Investing Activities | |||||||
| Capital Expenditure | (11.0) | (33.0) | (2.1) | (0.7) | (0.8) | (0.4) | (0.9) |
| Acquisitions | (69.3) | (2.2) | (0.0) | (48.1) | (23.1) | 0 | (0.2) |
| Purchases of Investments | (146.3) | (143.3) | (266.0) | (228.2) | (308.8) | 0 | 0 |
| Sales/Maturities of Investments | 296.4 | 177.4 | 285.1 | 356.4 | 11.3 | 0 | 0 |
| Other Investing Activities | (1.4) | (2.1) | 0.1 | 0 | (0.5) | 0 | (0.2) |
| Investing Cash Flow | 69.8 | (1.0) | 17.1 | 79.3 | (321.3) | (0.4) | (1.1) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (1.2) | 1.2 | – |
| Stock Repurchased | 0 | (0.2) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.1) | (5.5) | (0.1) | (1.2) | 213.8 | 0.0 | 0.1 |
| Financing Cash Flow | (8.9) | (5.8) | (0.1) | (1.1) | 332.3 | 1.2 | 0.1 |
| Cash Position | |||||||
| Net Change in Cash | 11.6 | (9.4) | (15.4) | 36.8 | (4.7) | (10.0) | (11.2) |
| Cash at Beginning | 19.6 | 29.0 | 44.4 | 7.6 | 12.3 | 22.3 | 33.5 |
| Cash at End | 31.2 | 19.6 | 29.0 | 44.4 | 7.6 | 12.3 | 22.3 |
| Free Cash Flow | (59.9) | (35.5) | (34.5) | (37.9) | (16.4) | (11.2) | (11.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 197.1 | 248.7 | 225.2 | 146.1 | 50.5 | 23.4 | 31.2 |
| Gross Profit | 41.1 | 58.9 | 42.1 | 22.3 | 10.5 | 2.3 | 4.7 |
| Operating Income | (22.4) | (33.9) | (68.1) | (53.5) | (24.1) | (10.4) | (11.5) |
| Net Income | 41.3 | (27.3) | (56.1) | (27.3) | (40.1) | (10.2) | (10.8) |
| EPS (Diluted) | -0.19 | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 | -1.47 |
| Balance Sheet | |||||||
| Cash & Equivalents | 31.0 | 18.4 | 27.9 | 41.3 | 2.6 | 12.2 | 1.3 |
| Total Assets | 325.5 | 256.7 | 294.9 | 325.0 | 335.9 | 17.7 | 277.7 |
| Total Debt | 3.3 | 9.3 | 24.5 | 18.3 | 0.7 | 1.9 | 0.5 |
| Stockholders' Equity | 279.1 | 221.9 | 234.3 | 274.5 | 291.4 | 11.1 | 5.0 |
| Cash Flow | |||||||
| Operating Cash Flow | (48.9) | (2.5) | (32.3) | (37.1) | (15.6) | (10.8) | (10.3) |
| Capital Expenditure | (11.0) | (33.0) | (2.1) | (0.7) | (0.8) | (0.4) | (0.9) |
| Free Cash Flow | (59.9) | (35.5) | (34.5) | (37.9) | (16.4) | (11.2) | (11.2) |